CEPHRADINE Drug Patent Profile
Which patents cover Cephradine, and when can generic versions of Cephradine launch?
Cephradine is a drug marketed by Barr, Ivax Sub Teva Pharms, Teva, and Vitarine. and is included in eight NDAs.
The generic ingredient in CEPHRADINE is cephradine. There is one drug master file entry for this compound. Additional details are available on the cephradine profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CEPHRADINE?
- What are the global sales for CEPHRADINE?
- What is Average Wholesale Price for CEPHRADINE?
Summary for CEPHRADINE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 7,585 |
| DailyMed Link: | CEPHRADINE at DailyMed |
Medical Subject Heading (MeSH) Categories for CEPHRADINE
US Patents and Regulatory Information for CEPHRADINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barr | CEPHRADINE | cephradine | CAPSULE;ORAL | 062850-001 | Apr 22, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Vitarine | CEPHRADINE | cephradine | CAPSULE;ORAL | 062813-001 | Feb 25, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ivax Sub Teva Pharms | CEPHRADINE | cephradine | CAPSULE;ORAL | 062762-002 | Mar 6, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
